Iodoxamate meglumine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for iodoxamate meglumine and what is the scope of patent protection?
Iodoxamate meglumine
is the generic ingredient in one branded drug marketed by Bracco and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for iodoxamate meglumine
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 3 |
DailyMed Link: | iodoxamate meglumine at DailyMed |
US Patents and Regulatory Information for iodoxamate meglumine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | CHOLOVUE | iodoxamate meglumine | INJECTABLE;INJECTION | 018076-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bracco | CHOLOVUE | iodoxamate meglumine | INJECTABLE;INJECTION | 018077-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for iodoxamate meglumine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | CHOLOVUE | iodoxamate meglumine | INJECTABLE;INJECTION | 018077-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Bracco | CHOLOVUE | iodoxamate meglumine | INJECTABLE;INJECTION | 018076-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |